Previous bioinformatics studies indicated that GINS2 might be the hub genes in the development of NASH to HCC and predicted poor prognosis in HCC, but there was no further experiment to verify its effects on NAFLD (Lian et al., 2018; Zhang et al., 2020). Here, GINS2 is linked to metabolic dysfunction-associated steatohepatitis.